Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - A systematic review of in vitro data

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 87, Issue 1, 2014, Pages 1-18

  Doktorovova, Slavomira ^a   Souto, Eliana B ^a,b   Silva, Amélia M ^a  

^a UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

Author keywords

Blood compatibility; Cytotoxicity; Genotoxicity; In vitro studies; Lipid nanoparticles; Nanostructured lipid carriers; Oxidative stress; Solid lipid nanoparticles

Indexed keywords

DOXORUBICIN; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; PACLITAXEL; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; BIOMATERIAL; DRUG CARRIER; LIPID; NANOPARTICLE; REACTIVE OXYGEN METABOLITE;

CELL VIABILITY; CYTOTOXICITY; HUMAN; IN VITRO STUDY; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; REVIEW; SYSTEMATIC REVIEW; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; LD 50; METABOLISM; PROCEDURES; TOXICITY; TOXICITY TESTING; TOXICOLOGY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; CELLS, CULTURED; DRUG CARRIERS; HUMANS; LETHAL DOSE 50; LIPIDS; NANOPARTICLES; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TOXICITY TESTS; TOXICOLOGY;

EID: 84901617260     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.02.005     Document Type: Review

References (138)

1. L. Battaglia, and M. Gallarate Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery Exp. Opin. Drug Deliv. 9 2012 497 508
2. R. Muller, R. Shegokar, and C. Keck 20 Years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications Curr. Drug Discov. Technol. 8 2011 207 227
3. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 2002 121 128
4. J. Pardeike, A. Hommoss, and R.H. Muller Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Int. J. Pharm. 366 2009 170 184
5. W. Mehnert, and K. Mader Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2001 165 196 (Pubitemid 32324113)
6. J.S. Lucks, R.H. Müller, and B. König Solid lipid nanoparticles (SLN) - an alternative parenteral drug carrier system Eur. J. Pharm. Biopharm. 38 1992 33S
7. W. Weyenberg, P. Filev, D. Van den Plas, J. Vandervoort, K. De Smet, P. Sollie, and A. Ludwig Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application Int. J. Pharm. 337 2007 291 298 (Pubitemid 46756044)
8. D.M. Ridolfi, P.D. Marcato, D. Machado, R.A. Silva, G.Z. Justo, and N. Duran In vitro cytotoxicity assays of solid lipid nanoparticles in epithelial and dermal cells J. Phys: Conf. Ser. 304 2012 012032
9. M. Nassimi, C. Schleh, H.D. Lauenstein, R. Hussein, H.G. Hoymann, W. Koch, G. Pohlmann, N. Krug, K. Sewald, S. Rittinghausen, A. Braun, and C. Müller-Goymann A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung Eur. J. Pharm. Biopharm. 75 2010 107 116
10. M. Nassimi, C. Schleh, H.-D. Lauenstein, R. Hussein, K. Lübbers, G. Pohlmann, S. Switalla, K. Sewald, M. Müller, N. Krug, C.C. Müller-Goymann, and A. Braun Low cytotoxicity of solid lipid nanoparticles in in vitro and ex vivo lung models Inhal. Toxicol. 21 2009 104 109
11. C. Olbrich, N. Scholer, K. Tabatt, O. Kayser, and R.H. Muller Cytotoxicity studies of Dynasan 114 solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production J. Pharm. Pharmacol. 56 2004 883 891 (Pubitemid 38885982)
12. R.H. Muller, S. Maassen, H. Weyhers, and W. Mehnert Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407 J. Drug Target. 4 1996 161 170 (Pubitemid 26390298)
13. R.H. Muller, D. Ruhl, S. Runge, K. Schulze-Forster, and W. Mehnert Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant Pharm. Res. 14 1997 458 462 (Pubitemid 27205004)
14. S. Petersen, F. Steiniger, D. Fischer, A. Fahr, and H. Bunjes The physical state of lipid nanoparticles influences their effect on in vitro cell viability Eur. J. Pharm. Biopharm. 79 2011 150 161
15. A.H. Silva, F.B. Filippin-Monteiro, B. Mattei, B.G. Zanetti-Ramos, and T.B. Creczynski-Pasa In vitro biocompatibility of solid lipid nanoparticles Sci. Total Environ. 432 2012 382 388
16. International Organization for Standardization, ISO 10993-5:2009 Biological Evaluation of Medical Devices Part 5: Tests for in Vitro Cytotoxicity, 2009.
17. N. Lewinski, V. Colvin, and R. Drezek Cytotoxicity of nanoparticles Small 4 2008 26 49
18. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
19. S. Gattefosse, Precirol ATO 5 Technical data sheet, in: S. Gattefosse (Ed.), France, 2009.
20. M.-K. Lee, S.-J. Lim, and C.-K. Kim Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles Biomaterials 28 2007 2137 2146 (Pubitemid 46198929)
21. R.S. Mulik, J. Monkkonen, R.O. Juvonen, K.R. Mahadik, and A.R. Paradkar Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis Int. J. Pharm. 398 2010 190 203
22. G. Repetto, A. del Peso, and J.L. Zurita Neutral red uptake assay for the estimation of cell viability/cytotoxicity Nat. Protoc. 3 2008 1125 1131
23. W. Strober, Trypan blue exclusion test of cell viability, in: John E. Coligan, et al. (Eds.), Current Protocols in Immunology, Appendix 3, Appendix 3B, 2001.
24. G. Fotakis, and J.A. Timbrell In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride Toxicol. Lett. 160 2006 171 177 (Pubitemid 41578961)
25. Q.H. Ma, Y.W. Wang, X.F. Lin, D. Luo, N. Gu, Preparation, characterization and photoprotection of tocopherol loaded nanostructured lipid carriers, in: IEEE/ICME International Conference on Complex Medical Engineering, 2007, CME 2007, 2007, pp. 203-208.
26. Y. Zhuang, B. Xu, F. Huang, J. Wu, and S. Chen Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model Pharmazie 67 2012 925 929
27. C. Freitas, and R.H. Muller Stability determination of solid lipid nanoparticles (SLN) in aqueous dispersion after addition of electrolyte J. Microencapsul. 16 1999 59 71 (Pubitemid 29045852)
28. A.C. Silva, A. Kumar, W. Wild, D. Ferreira, D. Santos, and B. Forbes Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles Int. J. Pharm. 436 2012 798 805
29. I. Rivolta, A. Panariti, B. Lettiero, S. Sesana, P. Gasco, M. Gasco, M. Masserini, and G. Miserocchi Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles J. Physiol. Pharmacol. 62 2011 45 53
30. C.W. How, R. Abdullah, and R. Abbasalipourkabir Characterization and cytotoxicity of nanostructured lipid carriers formulated with olive oil, hydrogenated palm oil and Polysorbate 80 IEEE Trans. Nanobiosci. 12 2013 72 78
31. A. Siddiqui, G.A. Patwardhan, Y.-Y. Liu, and S. Nazzal Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells Int. J. Pharm. 400 2010 251 259
32. S. Martins, S. Costa-Lima, T. Carneiro, A. Cordeiro-da-Silva, E.B. Souto, and D.C. Ferreira Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway Int. J. Pharm. 430 2012 216 227
33. W. Yu, C. Liu, Y. Liu, N. Zhang, and W. Xu Mannan-modified solid lipid nanoparticles for targeted gene delivery to Alveolar macrophages Pharmaceut. Res. 27 2010 1584 1596
34. J.A.R.d. Araújo, in: Triamcinolone Acetonide for Ocular Administration: Innovations in Drug Delivery and Therapeutics, Departament de Físicoquímica, Universitat de Barcelona, Barcelona, Spain, 2011.
35. L. Montenegro, A. Campisi, M.G. Sarpietro, C. Carbone, R. Acquaviva, G. Raciti, and G. Puglisi In vitro evaluation of idebenone-loaded solid lipid nanoparticles for drug delivery to the brain Drug Dev. Ind. Pharm. 37 2011 737 746
36. W. Yu, C. Liu, J. Ye, W. Zou, N. Zhang, and X. Wenfang Novel cationic SLN containing a synthesized single-tailed lipid as a modifier for gene delivery Nanotechnology 20 2009 215102
37. X.-Y. Ying, D. Cui, L. Yu, and Y.-Z. Du Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin Carbohydr. Polym. 84 2011 1357 1364
38. D. Peters, R.H. Muller, C. Keck, Development and physical stability of nanostructured lipid carriers (NLC) in buffer solution, in: Annual Meeting of the American Association of Pharmaceutical Scientists, Washington, DC, 2011.
39. M.A. Schubert, and C.C. Muller-Goymann Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier Eur. J. Pharm. Biopharm. 61 2005 77 86 (Pubitemid 41096691)
40. N. Schöler, C. Olbrich, K. Tabatt, R.H. Müller, H. Hahn, and O. Liesenfeld Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages Int. J. Pharm. 221 2001 57 67 (Pubitemid 32524035)
41. Z. Magdolenova, D. Bilanicova, G. Pojana, L.M. Fjellsbo, A. Hudecova, K. Hasplova, A. Marcomini, and M. Dusinska Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity J. Environ. Monit. 14 2012 455 464
42. F. Watari, N. Takashi, A. Yokoyama, M. Uo, T. Akasaka, Y. Sato, S. Abe, Y. Totsuka, and K. Tohji Material nanosizing effect on living organisms: non-specific, biointeractive, physical size effects J. R. Soc. Interface 6 2009 S371 S388
43. C. Carbone, B. Tomasello, B. Ruozi, M. Renis, and G. Puglisi Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design Eur. J. Med. Chem. 49 2012 110 117
44. R. Abbasalipourkabir, A. Salehzadeh, and R. Abdullah Cytotoxicity effect of solid lipid nanoparticles on human breast cancer cell lines Biotechnology 10 2011 528 533
45. H. Yang, C. Liu, D. Yang, H. Zhang, and Z. Xi Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition J. Appl. Toxicol. 29 2009 69 78
46. U. Ruktanonchai, P. Bejrapha, U. Sakulkhu, P. Opanasopit, N. Bunyapraphatsara, V. Junyaprasert, and S. Puttipipatkhachorn Physicochemical characteristics, cytotoxicity, and antioxidant activity of three lipid nanoparticulate formulations of alpha-lipoic acid AAPS PharmSciTech 10 2009 227 234
47. U. Ruktanonchai, U. Sakulkhu, P. Bejrapha, P. Opanasopit, N. Bunyapraphatsara, V. Junyaprasert, and S. Puttipipatkhachorn Effect of lipid types on physicochemical characteristics, stability and antioxidant activity of gamma-oryzanol-loaded lipid nanoparticles J. Microencapsul. 26 2009 614 626
48. S. Trombino, R. Cassano, R. Muzzalupo, A. Pingitore, E. Cione, and N. Picci Stearyl ferulate-based solid lipid nanoparticles for the encapsulation and stabilization of [beta]-carotene and [alpha]-tocopherol Colloids Surf., B: Biointerfaces 72 2009 181 187
49. A. Miglietta, R. Cavalli, C. Bocca, L. Gabriel, and M. Rosa Gasco Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel Int. J. Pharm. 210 2000 61 67 (Pubitemid 32332642)
50. R.R. Zhu, L.L. Qin, M. Wang, S.M. Wu, S.L. Wang, R. Zhang, Z.X. Liu, X.Y. Sun, and S.D. Yao Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles Nanotechnology 20 2009 055702
51. W. Zhang, J. Liu, S. Li, M. Chen, and H. Liu Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: influence of Poloxamer 188 coating on phagocytic uptake J. Microencapsul. 25 2008 203 209
52. E. Vighi, E. Leo, M. Montanari, A. Mucci, M. Hanuskova, and V. Iannuccelli Structural investigation and intracellular trafficking of a novel multicomposite cationic solid lipid nanoparticle platform as a pDNA carrier Ther. Deliv. 2 2011 1419 1435
53. D. Alukda, T. Sturgis, and B. Youan Formulation of tenofovir-loaded functionalized solid lipid nanoparticles intended for HIV prevention J. Pharm. Sci. 100 2011 3345 3356
54. S.G. Potta, S. Minemi, R.K. Nukala, C. Peinado, D.A. Lamprou, A. Urquhart, and D. Douroumis Preparation and characterization of ibuprofen solid lipid nanoparticles with enhanced solubility J. Microencapsul. 28 2010 74 81
55. D. Liu, Z. Liu, L. Wang, C. Zhang, and N. Zhang Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel Colloids Surf., B: Biointerfaces 85 2011 262 269
56. N. Schöler, H. Hahn, R.H. Müller, and O. Liesenfeld Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages Int. J. Pharm. 231 2002 167 176 (Pubitemid 34033676)
57. H. Yuan, J. Miao, Y.Z. Du, J. You, F.Q. Hu, and S. Zeng Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells Int. J. Pharm. 348 2008 137 145 (Pubitemid 350266242)
58. K. Tabatt, M. Sameti, C. Olbrich, R.H. Müller, and C.-M. Lehr Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer Eur. J. Pharm. Biopharm. 57 2004 155 162 (Pubitemid 38283690)
59. C. Erni, C. Suard, S. Freitas, D. Dreher, H.P. Merkle, and E. Walter Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells Biomaterials 23 2002 4667 4676 (Pubitemid 36151619)
60. K. Jores, W. Mehnert, M. Drechsler, H. Bunjes, C. Johann, and K. Mäder Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy J. Control. Release 95 2004 217 227 (Pubitemid 38230037)
61. J.C. Schwarz, A. Weixelbaum, E. Pagitsch, M. Low, G.P. Resch, and C. Valenta Nanocarriers for dermal drug delivery: influence of preparation method, carrier type and rheological properties Int. J. Pharm. 437 2012 83 88
62. A.V. Heydenreich, R. Westmeier, N. Pedersen, H.S. Poulsen, and H.G. Kristensen Preparation and purification of cationic solid lipid nanospheres - effects on particle size, physical stability and cell toxicity Int. J. Pharm. 254 2003 83 87 (Pubitemid 36259816)
63. X. Dong, C.A. Mattingly, M. Tseng, M. Cho, V.R. Adams, and R.J. Mumper Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization Eur. J. Pharm. Biopharm. 72 2009 9 17
64. J.M. Koziara, P.R. Lockman, D.D. Allen, and R.J. Mumper Paclitaxel nanoparticles for the potential treatment of brain tumors J. Control. Release 99 2004 259 269 (Pubitemid 39222111)
65. L. Serpe, M.G. Catalano, R. Cavalli, E. Ugazio, O. Bosco, R. Canaparo, E. Muntoni, R. Frairia, M.R. Gasco, M. Eandi, and G.P. Zara Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line Eur. J. Pharm. Biopharm. 58 2004 673 680 (Pubitemid 39297116)
66. X.-G. Zhang, J. Miao, Y.-Q. Dai, Y.-Z. Du, H. Yuan, and F.-Q. Hu Reversal activity of nanostructured lipid carriers loading cytotoxic drug in multi-drug resistant cancer cells Int. J. Pharm. 361 2008 239 244
67. V.K. Venishetty, R. Komuravelli, M. Kuncha, R. Sistla, and P.V. Diwan Increased brain uptake of docetaxel and ketoconazole loaded folate grafted solid lipid nanoparticles Nanomed. NBM 9 2013 111 121
68. L. Wang, M. Li, and N. Zhang Folate-targeted docetaxel-lipid-based- nanosuspensions for active-targeted cancer therapy Int. J. Nanomed. 7 2012 3281 3294
69. S.V. Mussi, R.C. Silva, M.C.d. Oliveira, C.M. Lucci, R.B.d. Azevedo, and L.A.M. Ferreira New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles Eur. J. Pharm. Sci. 48 2012 282 290
70. Y.-C. Kuo, and C.-T. Liang Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells Colloids Surf., B: Biointerfaces 85 2011 131 137
71. P. Zhang, G. Ling, X. Pan, J. Sun, T. Zhang, X. Pu, S. Yin, and Z. He Novel nanostructured lipid-dextran sulfate hybrid carriers (NLDCs) overcome tumor multidrug resistance of mitoxantrone hydrochloride Nanomed. NBM 8 2012 185 193
72. J. Varshosaz, F. Hassanzadeh, H. Sadeghi, and M. Shakery Folate targeted solid lipid nanoparticles of simvastatin for enhanced cytotoxic effects of doxorubicin in chronic myeloid leukemia Curr. Nanosci. 8 2012 249 258
73. J.S. Baek, and C.W. Cho 2-Hydroxypropyl-beta-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells J. Pharm. Pharmacol. 65 2012 72 78
74. X. Lin, R. Gao, Y. Zhang, N. Qi, Y. Zhang, K. Zhang, H. He, and X. Tang Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy Exp. Opin. Drug. Deliv. 9 2012 767 781
75. A.L.R.d. Souza, in: Desenvolvimento de nanopartículas lipídicas sólidas contendo praziquantel, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista. "Júlio de Mesquita Filho", Araraquara, S. Paulo, Brazil, 2011.
76. F. Wan, J. You, Y. Sun, X.-G. Zhang, F.-D. Cui, Y.-Z. Du, H. Yuan, and F.-Q. Hu Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro Int. J. Pharm. 359 2008 104 110
77. D.C. Drummond, C.O. Noble, Z. Guo, M.E. Hayes, C. Connolly-Ingram, B.S. Gabriel, B. Hann, B. Liu, J.W. Park, K. Hong, C.C. Benz, J.D. Marks, and D.B. Kirpotin Development of a highly stable and targetable nanoliposomal formulation of topotecan J Control. Release 141 2010 13 21
78. F. Lacoeuille, E. Garcion, J.P. Benoit, and A. Lamprecht Lipid nanocapsules for intracellular drug delivery of anticancer drugs J. Nanosci. Nanotechnol. 7 2007 4612 4617
79. G. Carneiro, E.L. Silva, L.A. Pacheco, E.M. de Souza-Fagundes, N.C. Correa, A.M. de Goes, M.C. de Oliveira, and L.A. Ferreira Formation of ion pairing as an alternative to improve encapsulation and anticancer activity of all-trans retinoic acid loaded in solid lipid nanoparticles Int. J. Nanomed. 7 2012 6011 6020
80. M. Wang, L. Qin, K. Li, R. Zhu, W. Wang, and S. Wang The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-d-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles AAPS PharmSciTech 13 2012 1348 1354
81. C. Han, C.M. Qi, B.K. Zhao, J. Cao, S.Y. Xie, S.L. Wang, and W.Z. Zhou Hydrogenated castor oil nanoparticles as carriers for the subcutaneous administration of tilmicosin: in vitro and in vivo studies J. Vet. Pharm. Ther. 32 2009 116 123
82. E.H. Gokce, G. Sandri, S. Egrilmez, M.C. Bonferoni, T. Guneri, and C. Caramella Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes Curr. Eye Res. 34 2009 996 1003
83. A.L.R. Souza, T. Andreani, S. Doktorovova, A.M. Silva, E.B. Souto, and M.P.D. Gremiao Development of solid lipid nanoparticles for praziquantel delivery: particle size characterization and cell toxicity assessment Sci. Pharm. 78 2010 576 10.3797/scipharm.cespt.8.LNT02
84. Y. Chen, L. Yuan, L. Zhou, Z. Zhang, W. Cao, and Q. Wu Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine Int. J. Nanomed. 7 2012 4581 4591
85. K. Teskac, and J. Kristl The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol Int. J. Pharm. 390 2010 61 69
86. F. Li, Y. Weng, L. Wang, H. He, J. Yang, and X. Tang The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers Int. J. Pharm. 393 2010 204 212
87. E.H. Gokce, E. Korkmaz, E. Dellera, G. Sandri, M.C. Bonferoni, and O. Ozer Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications Int. J. Nanomed. 7 2012 1841 1850
88. S. Wang, T. Chen, R. Chen, Y. Hu, M. Chen, and Y. Wang Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies Int. J. Pharm. 430 2012 238 246
89. J. Shen, Y. Deng, X. Jin, Q. Ping, Z. Su, and L. Li Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution Int. J. Pharm. 402 2010 248 253
90. R.R. Patlolla, M. Chougule, A.R. Patel, T. Jackson, P.N.V. Tata, and M. Singh Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers J. Control. Release 144 2010 233 241
91. R. Lopes, C.V. Eleuterio, L.M.D. Gonçalves, M.E.M. Cruz, and A.J. Almeida Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis Eur. J. Pharm. Sci. 45 2012 442 450
92. N.B. Wolf, S. Küchler, M.R. Radowski, T. Blaschke, K.D. Kramer, G. Weindl, B. Kleuser, R. Haag, and M. Schäfer-Korting Influences of opioids and nanoparticles on in vitro wound healing models Eur. J. Pharm. Biopharm. 73 2009 34 42
93. R.H. Müller, S. Gohla, and C.M. Keck State of the Artof nanocrystals-special features, production, nanotoxicology aspects & intracellular delivery Eur. J. Pharm. Biopharm. 78 2011 1 9
94. S.E.A. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, V.J. Madden, M.E. Napier, and J.M. DeSimone The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. U. S. A. 105 2008 11613 11618
95. C. Olbrich, U. Bakowsky, C.-M. Lehr, R.H. Müller, and C. Kneuer Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA J. Control. Release 77 2001 345 355 (Pubitemid 33145485)
96. H.R. Kim, I.K. Kim, K.H. Bae, S.H. Lee, Y. Lee, and T.G. Park Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA Mol. Pharm. 5 2008 622 631
97. T.C. Long, N. Saleh, R.D. Tilton, G.V. Lowry, and B. Veronesi Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity Environ. Sci. Technol. 40 2006 4346 4352 (Pubitemid 44092366)
98. X. Chen, Z. Zhong, Z. Xu, L. Chen, and Y. Wang 2′,7′- Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy Free Radical Res. 44 2011 587 604
99. M.M. Tarpey, D.A. Wink, and M.B. Grisham Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 2004 R431 R444
100. P. Picone, M.L. Bondi, G. Montana, A. Bruno, G. Pitarresi, G. Giammona, and M. Di Carlo Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: improved delivery by solid lipid nanoparticles Free Radical Res. 43 2009 1133 1145
101. M.L. Bondi, G. Montana, E.F. Craparo, P. Picone, G. Capuano, M.D. Carlo, and G. Giammona Ferulic acid-loaded lipid nanostructures as drug delivery systems for Alzheimers disease: preparation, characterization and cytotoxicity studies Curr. Nanosci. 5 2009 26 32
102. E.H. Gokce, E. Korkmaz, S. Tuncay-TanrIverdi, E. Dellera, G. Sandri, M.C. Bonferoni, and O. Ozer A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers Int. J. Nanomed. 2012 2012 5109 5117
103. V. Kakkar, and I.P. Kaur Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioral, biochemical and histopathological alterations in mice brain Food Chem. Toxicol. 49 2011 2906 2913
104. S. Doktorovova, A.M. Silva, I. Gaivão, J.P. Teixeira, E.B. Souto, and P. Martins-Lopes Comet assay reveals no genotoxicity risk of cationic solid lipid nanoparticles J. Appl. Toxicol. 2014 10.1002/jat.2961
105. S. Doktorovová, A.M. Silva, I. Gaivão, C.M. Lopes, E.B. Souto, J.P. Teixeira, P. Martins-Lopes, Genotoxicity evaluation of cationic solid lipid nanoparticles, in: International Conference on Environmental and Occupational Health 2011, Porto, Portugal, 2011.
106. H. Sies Biochemistry of oxidative stress Angew. Chem. Int. Ed. 25 1986 1058 1071
107. Y. Wang, and W. Wu In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages Drug Deliv. 13 2006 189 192
108. J. Koziara, J. Oh, W. Akers, S. Ferraris, and R. Mumper Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles Pharm. Res. 22 2005 1821 1828 (Pubitemid 41504335)
109. A. Jain, A. Agarwal, S. Majumder, N. Lariya, A. Khaya, H. Agrawal, S. Majumdar, and G.P. Agrawal Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug J. Control. Release 148 2010 359 367
110. A. Agarwal, S. Majumder, H. Agrawal, S. Majumdar, and G.P. Agrawal Cationized albumin conjugated solid lipid nanoparticles as vectors for brain delivery of an anti-cancer drug Curr. Nanosci. 7 2011 71 80
111. J.H. Healey Editorial: the imperative to authenticate cell lines Clin. Orthop. Relat. Res. 468 2010 3413 3414
112. J. Fangueiro, E. Gonzalez-Mira, P. Martins-Lopes, M. Egea, M. Garcia, S. Souto, and E. Souto A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing Pharm. Dev. Technol. 18 2013 545 549
113. C. Olbrich, R.H. Müller, K. Tabatt, O. Kayser, C. Schulze, and R. Schade Stable biocompatible adjuvants - a new type of adjuvant based on solid lipid nanoparticles: a study on cytotoxicity, compatibility and efficacy in chicken ATLA 30 2002 443 458
114. Z.H. Xu, L.L. Chen, W.W. Gu, Y. Gao, L.P. Lin, Z.W. Zhang, Y. Xi, and Y.P. Li The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma Biomaterials 30 2009 226 232
115. S. Martins, I. Tho, I. Reimold, G. Fricker, E. Souto, D. Ferreira, and M. Brandl Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies Int. J. Pharm. 439 2012 49 62
116. M.L. Bondi, E.F. Craparo, G. Giammona, M. Cervello, A. Azzolina, P. Diana, A. Martorana, and G. Cirrincione Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies Drug Deliv. 14 2007 61 67
117. N. Pedersen, S. Hansen, A.V. Heydenreich, H.G. Kristensen, and H.S. Poulsen Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands Eur. J. Pharm. Biopharm. 62 2006 155 162 (Pubitemid 43143267)
118. L. Hu, Y. Jia, and WenDing Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery Pharmazie 65 2010 585 587
119. E.H. Gokce, G. Sandri, M.C. Bonferoni, S. Rossi, F. Ferrari, T. Güneri, and C. Caramella Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity Int. J. Pharm. 364 2008 76 86
120. L. Zhou, Y. Chen, Z. Zhang, J. He, M. Du, and Q. Wu Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine Pharmazie 67 2012 304 310
121. T. Ramasamy, U.S. Khandasami, H. Ruttala, and S. Shanmugam Development of solid lipid nanoparticles enriched hydrogels for topical delivery of anti-fungal agent Macromol. Res. 20 2012 682 692
122. E. Vighi, M. Montanari, M. Hanuskova, V. Iannuccelli, G. Coppi, and E. Leo Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector Int. J. Pharm. 440 2013 161 169
123. D. Ling, B.-c. Bae, W. Park, and K. Na Photodynamic efficacy of photosensitizers under an attenuated light dose via lipid nano-carrier-mediated nuclear targeting Biomaterials 33 2012 5478 5486
124. M. Wang, L. Qin, K. Li, R. Zhu, W. Wang, and S. Wang The improvement of the anticancer effect of a novel compound benzoic acid, 2-hydroxy-, 2-d-ribofuranosylhydrazide (BHR) loaded in solid lipid nanoparticles AAPS PharmSciTech 13 2012 1348 1354
125. S. Taveira, F.A. de Campos, L.M.P. jo, D.C.A.S. de Santana, A. Nomizo, L.A.P. de Freitas, and R.F.V. Lopez Development of cationic solid lipid nanoparticles with factorial design-based studies for topical administration of doxorubicin J. Biomed. Nanotechnol. 8 2012 219 228
126. R. Asasutjarit, S.-I. Lorenzen, S. Sirivichayakul, K. Ruxrungtham, U. Ruktanonchai, and G. Ritthidej Effect of solid lipid nanoparticles formulation compositions on their size, zeta potential and potential for in vitro pHIS-HIV-hugag transfection Pharm. Res. 24 2007 1098 1107 (Pubitemid 46798889)
127. W.H. Kong, K. Park, M.-Y. Lee, H. Lee, D.K. Sung, and S.K. Hahn Cationic solid lipid nanoparticles derived from apolipoprotein-free LDLs for target specific systemic treatment of liver fibrosis Biomaterials 34 2013 542 551
128. J. Miao, Y.-Z. Du, H. Yuan, X.-G. Zhang, and F.-Q. Hu Drug resistance reversal activity of anticancer drug loaded solid lipid nanoparticles in multi-drug resistant cancer cells Colloid Surf., B 110 2013 74 80
129. S.M. Martins, B. Sarmento, C. Nunes, M. Lucio, S. Reis, and D.C. Ferreira Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration Eur. J. Pharm. Biopharm. 85 2013 488 502
130. M. Videira, A.J. Almeida, and A. Fabra Preclinical evaluation of a pulmonary delivered paclitaxel-loaded lipid nanocarrier antitumor effect Nanomedicine 8 2012 1208 1215
131. E. Vighi, M. Montanari, M. Hanuskova, V. Iannuccelli, G. Coppi, and E. Leo Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector Int. J. Pharm. 440 2013 161 169
132. M.Á. Aznar, B. Lasa-Saracíbar, A. Estella-Hermoso de Mendoza, and M.J. Blanco-Prieto Efficacy of edelfosine lipid nanoparticles in breast cancer cells Int. J. Pharm. 454 2013 720 726
133. S.V. Mussi, R.C. Silva, M.C.d. Oliveira, C.M. Lucci, R.B.d. Azevedo, and L.A.M. Ferreira New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles Eur. J. Pharm. Sci. 48 2012 282 290
134. A. Chuan, Y. Li, L. Yang, X. Sun, Q. Zhang, T. Gong, and Z. Zhang Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles J. Nanopart. Res. 15 2013 1634 10.1007/s11051-013-1634-1
135. A. Khajavinia, J. Varshosaz, and A. Dehkordi Targeting etoposide to acute myelogenous leukaemia cells using nanostructured lipid carriers coated with transferrin Nanotechnology 23 2012 405101
136. C.W. How, R. Abdullah, and R. Abbasalipourkabir Characterization and cytotoxicity of nanostructured lipid carriers formulated with olive oil, hydrogenated palm oil and Polysorbate 80 IEEE Trans. Nanobiosci. 12 2012 72 78
137. G. Carneiro, E.L. Silva, L.A. Pacheco, E.M. de Souza-Fagundes, N.C. Correa, A.M. de Goes, M.C. de Oliveira, and L.A. Ferreira Formation of ion pairing as an alternative to improve encapsulation and anticancer activity of all-trans retinoic acid loaded in solid lipid nanoparticles Int. J. Nanomed. 7 2012 6011 6020
138. C. Vitorino, J. Almeida, L.M. Gonçalves, A.J. Almeida, J.J. Sousa, and A.A.C.C. Pais Co-encapsulating nanostructured lipid carriers for transdermal application: from experimental design to the molecular detail J. Control. Release 167 2013 301 314